ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 95 filers reported holding ATHIRA PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,370,690 | -31.5% | 3,153,807 | 0.0% | 0.04% | -31.5% |
| Q2 2023 | $9,303,731 | +58.3% | 3,153,807 | +34.2% | 0.05% | +68.8% |
| Q1 2023 | $5,875,888 | -1.4% | 2,350,355 | +25.0% | 0.03% | -11.1% |
| Q4 2022 | $5,959,080 | +92.8% | 1,879,836 | +80.6% | 0.04% | +80.0% |
| Q3 2022 | $3,091,000 | -2.6% | 1,040,834 | 0.0% | 0.02% | +11.1% |
| Q2 2022 | $3,175,000 | -70.8% | 1,040,834 | +29.1% | 0.02% | -71.4% |
| Q1 2022 | $10,886,000 | +3.6% | 806,367 | 0.0% | 0.06% | +23.5% |
| Q4 2021 | $10,507,000 | +38.9% | 806,367 | 0.0% | 0.05% | +54.5% |
| Q3 2021 | $7,564,000 | -8.4% | 806,367 | 0.0% | 0.03% | -8.3% |
| Q2 2021 | $8,257,000 | -44.3% | 806,367 | 0.0% | 0.04% | -43.8% |
| Q1 2021 | $14,837,000 | -46.3% | 806,367 | 0.0% | 0.06% | -38.5% |
| Q4 2020 | $27,618,000 | +69.6% | 806,367 | -8.6% | 0.10% | +60.0% |
| Q3 2020 | $16,288,000 | – | 882,352 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 714,763 | $2,265,799 | 2.16% |
| Perceptive Advisors | 4,797,278 | $15,207,371 | 0.43% |
| Potomac Capital Management, Inc. | 80,000 | $254 | 0.30% |
| Bristlecone Advisors, LLC | 696,629 | $2,208,314 | 0.27% |
| TANG CAPITAL MANAGEMENT LLC | 485,234 | $1,538,192 | 0.22% |
| RA Capital Management | 1,881,300 | $5,963,721 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 270,989 | $859 | 0.11% |
| PATHSTONE FAMILY OFFICE, LLC | 3,631,080 | $8,182,650 | 0.07% |
| Laird Norton Wetherby Trust Company, LLC | 130,000 | $412,100 | 0.06% |
| Forefront Analytics, LLC | 22,350 | $70,851 | 0.04% |